Someone just wrote this on the other board! LMAO Almost
Someone just wrote this on the other board! LMAO Almost spit upmy lunch.
I KNEW IT!! I stumbled across t d bo wie kn ife's OBSESSIVE posts by accident - which is not hard to do - as of this moment, he has posted 14 times, regarding Treaty. FOURTEEN TIMES-TODAY! LOL.
At first, I was completely taken in by the copious amount of posts and his obsessive preoccupation with TREATY and those directly and indirectly involved with TREATY. However, I became even more intrigued when the rants started to sound eerily familiar---- the reason why?--I KNOW HIM! well, I know OF him.
Years ago, he used to be connected to someone who is now involved with Treaty. "USED TO BE" being the operative words...HIS TUNURE ENDED BADLY... and now he has a hard on for everyone involved. He clearly cannot shrug it off. He has turned completely 'FATAL ATTRACTION"--stooping to opening several accounts on this site under different monikers in a misspent effort to try to make his rants relevant. Have you ever noticed how there's just a few accounts all SAYING THE SAME THING? and how someone always seems to respond almost IMMEDIATELY, singing the same tune? It's because IT'S ONE PERSON!!
Dear T D BO WIE KNI FE: Are you calling these people and then hanging up? Do you have their photos taped to the wall in your darkened bedroom? Seriously, more than 10,000 posts?--get over it, and get on with your life! Stop honing your ability to suffer! It's pathetic!
It's like watching a pit bull trying to duck hunt. You keep trotting back from the pond with nothing but a mouth full of bloody feathers thinking you've done a great job and not understanding why everybody keeps petting the Texas Labrador with the bandanna tied around his neck. It's painful to watch.
Oh and here's a little piece of advice--If you don't want to get caught trying to pull off your adulterated little plan, THEN, DON'T GET DRUNK AT DINNER PARTIES AND BLAB YOUR CORRUPT LITTLE SHAM!! OR AT LEAST LEARN TO HOLD YOUR LIQUOR!!
Treaty Energy Corporation (TECO) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
Top 5 Most Recently Viewed Articles
Markets in Germany Prepare for Fluctuations As trading wrapped up on Wednesday, the German stock market exhibited a mixed bag of results. While certain sectors, such as Food & Beverages, Media, and Financial Services, reported gains, others faced setbacks. The Consumer & Cyclical, Construction, and Pharmaceuticals & Healthcare sectors saw declines, reflecting the market's...
Continue Reading
Teradyne's Q3 Earnings Exceed Expectations Teradyne Incorporated (NASDAQ: TER), a prominent player in automated test equipment, has released its third-quarter results, building a narrative of success and optimism. The company reported impressive sales figures of $737 million, with non-GAAP earnings per share (EPS) reaching $0.90, bolstered by a solid gross margin of...
Continue Reading
So-Young's Strategic Shift in ADS Ratio So-Young International Inc. (NASDAQ: SY), a leading aesthetic treatment platform, has recently announced plans to change the ratio of its American depositary shares (ADSs) to Class A ordinary shares. This strategic decision aims to refine its trading dynamics, enhancing value for its shareholders. Details of the ADS Ratio Change The...
Continue Reading
Contextual Overview of GitLab's Recent Investor Challenges In a rapidly evolving technological landscape, GitLab Inc. stands at a critical juncture as investors navigate its latest developments and challenges. Recent announcements regarding financial performance have sparked interest and concern among stakeholders. Understanding the implications of these changes is...
Continue Reading
15 Years of Innovation in Specialty Pharmacy Senderra Specialty Pharmacy has proudly reached a remarkable milestone—15 years of providing top-tier healthcare solutions in the specialty pharmacy sector. This anniversary embodies a journey marked by significant advancements and unwavering commitment to revolutionizing patient care. Transforming Patient Experiences Since...
Continue Reading
